Results 101 to 110 of about 893,574 (181)
A Novel β-lactam/β-lactamase Inhibitor: Ceftolozane/tazobactam
Ceftolozane/tazobactam is a novel generation cephalosporin and β-lactamase inhibitor combination antibiotic. It was approved for the treatment of adults (18 years and older) with complicated intraabdominal infections used in combination with ...
Kıvanç ŞEREFHANOĞLU
doaj +1 more source
Zinc and antibiotic resistance: metallo-β-lactamases and their synthetic analogues
Antibiotic resistance to clinically employed β-lactam antibiotics currently poses a very serious threat to the clinical community. The origin of this resistance is the expression of several β-lactamases that effectively hydrolyze the amide bond in β ...
Mugesh, Govindasamy, Tamilselvi, A.
core +1 more source
Background: The intestinal colonization and transmission of antibiotic-resistant Enterobacteriales to renal transplant recipients may pose a threat to them because they are profoundly immunocompromised and vulnerable to infection.
Bindira Joshi +6 more
doaj +1 more source
Carbapenem-resistant bacteria pose a major health threat by expressing metallo-β-lactamases (MβLs), enzymes able to hydrolyse these life-saving drugs. Here the authors use biophysical and computational methods and show that different MβLs share the same ...
María-Natalia Lisa +10 more
doaj +1 more source
An overview of the production of AmpC and Metallo-β-Lactamase enzymes in Escherichia coli [PDF]
Escherichia coli is a Gram-negative, rod-shaped bacterium, responsible for 90% of all community-acquired infections and 50% of hospital-acquired infections, with opportunistic infections found in intensive care unit (ICU) patients.
Kirandeep Kaur
doaj
Background. The situation regarding the prevalence of resistant pathogens, types of β-lactamase products, and, accordingly, the justification of rational approaches to antibacterial therapy in Ukraine remains insufficiently studied.
V.A. Korsunov +7 more
doaj +1 more source
N‑Aryl Mercaptopropionamides as Broad-Spectrum Inhibitors of Metallo-β-Lactamases
Drug-resistant pathogens pose a global challenge to public health as they cause diseases that are extremely difficult to cure. Metallo-β-lactamases (MBLs) are a diverse set of zinc-containing enzymes that catalyze the hydrolysis of β-lactam drugs ...
Marco J. Rotter (12114333) +15 more
core +2 more sources
Assay Platform for Clinically Relevant Metallo-β-lactamases
Metallo-β-lactamases (MBLs) are a growing threat to the use of almost all clinically used β-lactam antibiotics. The identification of broad-spectrum MBL inhibitors is hampered by the lack of a suitable screening platform, consisting of appropriate ...
James Spencer (554121) +9 more
core +1 more source
Strategies to Name Metallo-β-Lactamases and Number Their Amino Acid Residues. [PDF]
Oelschlaeger P, Kaadan H, Dhungana R.
europepmc +1 more source
Objective: Urinary tract infections (UTI) are among the most common infections in elderly hospitalized patients, often caused by multi-drug resistant (MDR) organisms and characterized by poor clinical outcomes.
Gabriele Giuliano +8 more
doaj +1 more source

